Volume 13, Number 5—May 2007
Letter
Expanded-spectrum β-Lactamase and Plasmid-mediated Quinolone Resistance
Table
Strain†/Ref. | Spp. of origin | Country | Year of isolation | Plasmid size (kb) | ESBL | QnrA1 | Replicon | Associated non–β-lactam resistance markers |
---|---|---|---|---|---|---|---|---|
Escherichia coli TcE1 (5) |
E. coli |
Thailand |
1999 |
160 |
VEB-1 |
+ |
A/C2 |
NAL, K, SSS, C, RA |
E. coli TcE4 (5) |
E. coli |
Thailand |
1999 |
150 |
VEB-1 |
+ |
A/C2 |
NAL, K, TM, SSS, C, RA |
E. coli TcE5 (5) |
E. coli |
Thailand |
1999 |
150 |
VEB-1 |
+ |
A/C2 |
NAL, K, TM, SSS, SXT |
E. coli TcE7 (5) |
E. coli |
Thailand |
1999 |
150 |
VEB-1 |
+ |
A/C2 |
NAL, K, TM, SSS, C, RA |
E. coli TcE8 (5) |
E. coli |
Thailand |
1999 |
150 |
VEB-1 |
+ |
A/C2 |
NAL, K, TM, SSS, TE |
E. coli TcE16 (5) |
E. coli |
Thailand |
1999 |
140 |
VEB-1 |
+ |
A/C2 |
NAL, K, TM, SSS, RA |
E. coli TcE18 (5) |
E. coli |
Thailand |
1999 |
180 |
VEB-1 |
+ |
A/C2 |
NAL, K, SSS, C, RA |
E. coli Tc(pl) (5) |
E. coli |
Canada |
2000 |
180 |
VEB-1 |
+ |
A/C2 |
NAL, K, SSS, C, RA |
E. coli Tc(pQR1) (4) |
E. coli |
France |
2003 |
180 |
VEB-1 |
+ |
A/C2 |
NAL, K, SSS, C, RA, SXT |
E. coli Tc(GOC) (4) |
Enterobacter cloacae |
France |
2003 |
190 |
VEB-1 |
+ |
A/C2, FIB |
NAL, K, TM, SSS, C |
Citrobacter freundii LUT (3) |
C. freundii |
Turkey |
2004 |
ND |
VEB-1 |
+ |
A/C2, FIB, K |
NA |
Providencia stuartii 15 (this study) |
P. stuartii |
Algeria |
2004 |
ND |
VEB-1 |
– |
A/C2 |
NA |
E. coli TcMAA (this study) |
Proteus mirabilis |
Algeria |
2004 |
190 |
VEB-1 |
– |
A/C2 |
K, TM, SSS, C, SXT |
E. coli TcK147 (7) |
Klebsiella pneumoniae |
Australia |
2002 |
160 |
SHV-12 |
+ |
HI2, A/C1, P |
NAL, K, TM, C, TE, SXT |
E. cloacae A1 (8) |
E. cloacae |
France |
2004 |
75 |
SHV-12 |
+ |
HI2 |
NA |
E. coli TcA2 (8) |
Enterobacter aerogenes |
France |
2005 |
150 |
SHV-12 |
+ |
FII |
NAL, K, TM, TE |
E. coli TcA3 (8) | K. pneumoniae | France | 2005 | 40 | – | + | I1, K | NAL, K, TM, C, TE |
*Ref., reference; ESBL, extended-spectrum β-lactamase; NAL, nalidixic acid; K, kanamycin; SSS, sulfonamides; C, chloramphenicol; RA, rifampin; TM, tobramycin; SXT, trimethoprim-sulfamethoxazole; TE, tetracycline; ND, not determinable; NA, not applicable.
†Tc indicates that this is a transconjugant or a transformant.
References
- Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351:797–9. DOIPubMedGoogle Scholar
- Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006;6:629–40. DOIPubMedGoogle Scholar
- Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother. 2005;56:463–9. DOIPubMedGoogle Scholar
- Poirel L, Van De Loo M, Mammeri H, Nordmann P. Association of plasmid-mediated quinolone resistance with extended-spectrum β-lactamase VEB-1. Antimicrob Agents Chemother. 2005;49:3091–4. DOIPubMedGoogle Scholar
- Girlich D, Poirel L, Leelaporn A, Karim A, Tribuddharat C, Fennewald M, Molecular epidemiology of the integron-located VEB-1 extended-spectrum β-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol. 2001;39:175–82. DOIPubMedGoogle Scholar
- Poirel L, Pitout JD, Calvo L, Rodriguez-Martinez JM, Church D, Nordmann P. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother. 2006;50:1525–7. DOIPubMedGoogle Scholar
- Rodriguez-Martinez JM, Poirel L, Pascual A, Nordmann P. Plasmid-mediated quinolone resistance in Australia. Microb Drug Resist. 2006;12:99–102. DOIPubMedGoogle Scholar
- Poirel L, Leviandier C, Nordmann P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae in a French University Hospital. Antimicrob Agents Chemother. 2006;50:3992–7. DOIPubMedGoogle Scholar
- Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219–28. DOIPubMedGoogle Scholar
- Carattoli A, Miriagou V, Bertini A, Loli A, Colinon C, Villa L, Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg Infect Dis. 2006;12:1145–8.PubMedGoogle Scholar
Page created: June 23, 2010
Page updated: June 23, 2010
Page reviewed: June 23, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.